Skip to main content
Top
Published in: Rheumatology International 3/2024

27-08-2023 | ANCA-Associated Vasculitis | Case Based Review

Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature

Authors: Cengiz Korkmaz, Reşit Yıldırım, Mustafa Dinler, Döndü U. Cansu

Published in: Rheumatology International | Issue 3/2024

Login to get access

Abstract

IgG4-related disease (IgG4-RD) is a fibroinflammatory condition that is characterized by storiform fibrosis, infiltration of IgG4-positive lymphocytes, obliterative phlebitis, and high IgG4 levels. Since IgG4-RD affects a wide variety of organs, a differential diagnosis must include multiple conditions. IgG4-RD is also believed to coexist with certain diseases. In recent years, case reports and case series describing the co-occurrence of IgG4-RD and ANCA-associated vasculitis (AAV) have been published. We intended to evaluate patients with IgG4-RD and AAV overlap in the literature using a case similar to one that was diagnosed and monitored in our department. We searched the databases of Web of Science, Scopus, and Google Scholar as well as PubMed with the keywords ANCA, IgG4, IgG4-RD, granulomatosis with polyangiitis, Wegener’s granulomatosis, microscopic polyangiitis, Eosinophilic granulomatosis with polyangiitis, and Churg–Strauss syndrome. Cases and Case series addressing the coexistence of IgG4-RD and AAV have been selected. Comprehensive diagnostic criteria are used to diagnose IgG4-RD. The Chapel Hill Consensus Conference nomenclature criteria were used for the inclusion of AAV. Out of a total of 910 publications, 20 articles, including 65 cases, were found to be eligible. Forty-seven cases with IgG4-RD were evaluated as definitive (71.2%), 10 cases as probable (15.1%), and 9 cases as possible IgG4-RD (13.6%). 26 patients were diagnosed with GPA, 1 patient with localized GPA, 23 patients with MPA, and 4 patients with EGPA. The aorta, lacrimal tissue, pancreas, and retroperitoneum are the sites of IgG4-RD rather than AAV. AAV and IgG4-RD might coexist in the same patient. IgG4-RD is mainly associated with GPA.
Literature
1.
go back to reference Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team (2010) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatol 22:1–14. https://doi.org/10.1007/s10165-011-0508-6CrossRef Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team (2010) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatol 22:1–14. https://​doi.​org/​10.​1007/​s10165-011-0508-6CrossRef
3.
go back to reference Boncoraglio MT, Prieto-González S, Fernandes-Serodio J, Corral-Molina JM, Solé M, Hernández-Rodríguez J (2021) Simultaneous presentation of granulomatosis with polyangiitis (GPA) and immunoglobulin G4-related disease (IgG4-RD). Leaving an open question: widening the spectrum of a single disease or real overlap? Modern Rheumatol Case Reports 5:108–112. https://doi.org/10.1080/24725625.2020.1782028CrossRef Boncoraglio MT, Prieto-González S, Fernandes-Serodio J, Corral-Molina JM, Solé M, Hernández-Rodríguez J (2021) Simultaneous presentation of granulomatosis with polyangiitis (GPA) and immunoglobulin G4-related disease (IgG4-RD). Leaving an open question: widening the spectrum of a single disease or real overlap? Modern Rheumatol Case Reports 5:108–112. https://​doi.​org/​10.​1080/​24725625.​2020.​1782028CrossRef
7.
go back to reference Kawashima H, Utsugi A, Shibamiya A, Iida K, Mimura N, Ohashi H, Hase R, Kawakami M, Yanagisawa T, Hiraguri M (2019) Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature. Immunol Res 67:99–107. https://doi.org/10.1007/s12026-019-9070-7CrossRefPubMed Kawashima H, Utsugi A, Shibamiya A, Iida K, Mimura N, Ohashi H, Hase R, Kawakami M, Yanagisawa T, Hiraguri M (2019) Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature. Immunol Res 67:99–107. https://​doi.​org/​10.​1007/​s12026-019-9070-7CrossRefPubMed
17.
go back to reference Wang GQ, Chen YP, Cheng H, Xu XY, Sun LJ, Dong HR (2019) Antineutrophil cytoplasmic antibody and/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis. Clin Exp Rheumatol 37:279–285PubMed Wang GQ, Chen YP, Cheng H, Xu XY, Sun LJ, Dong HR (2019) Antineutrophil cytoplasmic antibody and/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis. Clin Exp Rheumatol 37:279–285PubMed
21.
go back to reference Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16:1036–1043. https://doi.org/10.1016/j.autrev.2017.07.020CrossRefPubMed Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16:1036–1043. https://​doi.​org/​10.​1016/​j.​autrev.​2017.​07.​020CrossRefPubMed
27.
go back to reference Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Watts RA (2013) 2012 revised international chapel hill consensus conference nomenclature of Vasculitides. Arthritis Rheumatism 65:1–11. https://doi.org/10.1002/art.37715CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Watts RA (2013) 2012 revised international chapel hill consensus conference nomenclature of Vasculitides. Arthritis Rheumatism 65:1–11. https://​doi.​org/​10.​1002/​art.​37715CrossRefPubMed
30.
go back to reference Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH, Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group (2020) The 2019 American college of rheumatology/European league against rheumatism classification criteria for IgG4-related disease. Annals Rheumatic Dis 79:77–87. https://doi.org/10.1136/annrheumdis-2019-216561CrossRef Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH, Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group (2020) The 2019 American college of rheumatology/European league against rheumatism classification criteria for IgG4-related disease. Annals Rheumatic Dis 79:77–87. https://​doi.​org/​10.​1136/​annrheumdis-2019-216561CrossRef
33.
go back to reference Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, Terrier B, Loundou A, Morel N, Audia S, Maurier F, Graveleau J, Hamidou M, Forestier A, Palat S, Bernit E, Bonotte B, Farnarier C, Harlé JR, Costedoat-Chalumeau N, Schleinitz N (2017) T Cell polarization toward TH2/TFH2 and TH17/TFH17 in patients with IgG4-related disease. Front Immunol 8:235. https://doi.org/10.3389/fimmu.2017.00235CrossRefPubMedPubMedCentral Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, Terrier B, Loundou A, Morel N, Audia S, Maurier F, Graveleau J, Hamidou M, Forestier A, Palat S, Bernit E, Bonotte B, Farnarier C, Harlé JR, Costedoat-Chalumeau N, Schleinitz N (2017) T Cell polarization toward TH2/TFH2 and TH17/TFH17 in patients with IgG4-related disease. Front Immunol 8:235. https://​doi.​org/​10.​3389/​fimmu.​2017.​00235CrossRefPubMedPubMedCentral
35.
go back to reference Al-Soudi A, Doorenspleet ME, Esveldt RE, Burgemeister LT, Hak AE, van den Born BJH, Tas SW, van Vollenhoven RF, Klarenbeek PL, de Vries N (2019) IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study. Arthritis Res Ther 21:43. https://doi.org/10.1186/s13075-018-1806-6CrossRefPubMedPubMedCentral Al-Soudi A, Doorenspleet ME, Esveldt RE, Burgemeister LT, Hak AE, van den Born BJH, Tas SW, van Vollenhoven RF, Klarenbeek PL, de Vries N (2019) IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study. Arthritis Res Ther 21:43. https://​doi.​org/​10.​1186/​s13075-018-1806-6CrossRefPubMedPubMedCentral
Metadata
Title
Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature
Authors
Cengiz Korkmaz
Reşit Yıldırım
Mustafa Dinler
Döndü U. Cansu
Publication date
27-08-2023
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 3/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-023-05419-x

Other articles of this Issue 3/2024

Rheumatology International 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.